Reclassify High-Grade Serous Ovarian Cancer Patients Into Different Molecular Subtypes With Discrepancy Prognoses and Therapeutic Responses Based on Cancer-Associated Fibroblast-Enriched Prognostic Genes.
Saved in:
| Title: | Reclassify High-Grade Serous Ovarian Cancer Patients Into Different Molecular Subtypes With Discrepancy Prognoses and Therapeutic Responses Based on Cancer-Associated Fibroblast-Enriched Prognostic Genes. |
|---|---|
| Authors: | Liu, Xiangxiang1 (AUTHOR), Ping, Guoqiang2 (AUTHOR), Ji, Dongze2 (AUTHOR), Wen, Zhifa1 (AUTHOR), Chen, Yajun1 (AUTHOR) Yajunchen_doctor@163.com |
| Source: | Biomedical Engineering & Computational Biology. 8/30/2024, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 11795972 |
|---|---|
| DOI: | 10.1177/11795972241274024 |